Aristippos Gennadios, President Softgel & Oral Technology at Catalent, Inc. (CTLT), sold 27,324 shares at $102.80 ($2.8M) on 2020-12-21, disclosed to the SEC on 2020-12-23.
Open-market sale of $2.8M CTLT by President Softgel & Oral Technology. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $102.80 | 9,726 | $1000K | 35.6% |
| 2 | $102.80 | 9,726 | $1000K | 35.6% |
| 3 | $102.95 | 3,936 | $405K | 14.4% |
| 4 | $102.95 | 3,936 | $405K | 14.4% |
| Total | $102.84 avg | 27,324 | $2.8M | 100% |
| Filing → |
| CTLT | SELL | 2023-08-25 | $18K | — | Filing → |
| CTLT | SELL | 2023-08-03 | $13K | — | Filing → |
| CTLT | SELL | 2022-08-26 | $339K | — | Filing → |